SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.
about
Exploiting Epigenetic Alterations in Prostate Cancer.Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.miR‑30c suppresses prostate cancer survival by targeting the ASF/SF2 splicing factor oncoprotein.AP4 modulated by the PI3K/AKT pathway promotes prostate cancer proliferation and metastasis of prostate cancer via upregulating L-plastin.SPOP mutation drives prostate neoplasia without stabilizing oncogenic transcription factor ERG.BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations.Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors.The Genomics of Prostate Cancer: emerging understanding with technologic advances.Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer.Prostatic cancers: understanding their molecular pathology and the 2016 WHO classification.Systematic characterization of pan-cancer mutation clusters.Key genes and pathways in measles and their interaction with environmental chemicals.Dual inhibition of AKT-mTOR and AR signaling by targeting HDAC3 in PTEN- or SPOP-mutated prostate cancer.Genetics and biology of prostate cancerRecent advances in prostate cancer research: large-scale genomic analyses reveal novel driver mutations and DNA repair defectsFunctional roles of Speckle-Type Poz (SPOP) Protein in Genomic stability
P2860
Q33755160-6D77CA4D-94FD-425A-AA8E-32BDE9F130F7Q38626078-0D174208-5888-4074-A775-2E58A0FFCA76Q42546726-DBF9211D-4AA3-42A4-BEEA-B0472DA585D6Q47156035-94BC19B7-48FF-454F-8F79-1776D88D0B0BQ47333876-37C284AE-B693-42EC-A547-53EDA7E09297Q47651456-7F4C67E1-85F6-4151-80C0-08CEAA80AD25Q47956425-A8F2B41D-C294-4EC8-8433-193ED8EF70F4Q48317607-FBB69D60-97A1-485B-8421-5E0FD0590C71Q50420907-428BAD71-23D5-4390-8364-B483076EB9DDQ52629153-8CEDDAA6-4457-4132-ACC5-A57BF7A1C95CQ52639487-79303134-B9F4-4BE8-BFF7-44992C2E1F43Q55256106-1711063F-3BEC-4115-9406-F367382A44ECQ55337031-3A6B3863-0A04-4E76-B663-877B197DE0DAQ57106917-B87AFE55-FD33-4686-97E6-B51675DB9C77Q57108205-D6FB386E-3FB4-477C-BF37-6E800B4D336AQ57116830-19872424-EA40-4BC1-9199-AA8F37AA5F48
P2860
SPOP Mutation Drives Prostate Tumorigenesis In Vivo through Coordinate Regulation of PI3K/mTOR and AR Signaling.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
SPOP Mutation Drives Prostate ...... of PI3K/mTOR and AR Signaling.
@en
SPOP Mutation Drives Prostate ...... of PI3K/mTOR and AR Signaling.
@nl
type
label
SPOP Mutation Drives Prostate ...... of PI3K/mTOR and AR Signaling.
@en
SPOP Mutation Drives Prostate ...... of PI3K/mTOR and AR Signaling.
@nl
prefLabel
SPOP Mutation Drives Prostate ...... of PI3K/mTOR and AR Signaling.
@en
SPOP Mutation Drives Prostate ...... of PI3K/mTOR and AR Signaling.
@nl
P2093
P2860
P50
P1433
P1476
SPOP Mutation Drives Prostate ...... of PI3K/mTOR and AR Signaling
@en
P2093
Andrea Sboner
Anton Poliakov
Arul M Chinnaiyan
Brian D Robinson
Dennis Huang
Lalit Ponnala
Lesa D Deonarine
Michael A Augello
Michael Ittmann
P2860
P304
P356
10.1016/J.CCELL.2017.02.004
P577
2017-03-01T00:00:00Z